The phrase "almost all trials of" is correct and usable in written English.
It can be used when discussing the majority of trials related to a specific subject or context, often in scientific or research discussions.
Example: "Almost all trials of the new medication showed promising results in reducing symptoms."
Alternatives: "nearly all studies of" or "most trials of".
An important finding of almost all trials concerning the conjugate pneumococcal vaccine is not only a significant reduction in nasopharyngeal carriage of pneumococci serotypes included in PCV7 but also a concomitant increase in carriage of non-PCV7 serotypes, in 39% up to 79% of cases [ 33, 34].
Almost all trials excluded current or recent use of drugs that are likely to interfere with measurements; typically, these were analgesics or low-dose aspirin, and recent prior use of aspirin, NSAIDs, antacids, histamine antagonists, or proton pump inhibitors.
The widespread recognition of the value of this clinical scenario for such research is illustrated by the fact that almost all clinical trials of a significant size now have an associated correlative science committee dealing with this specific issue.
The Sc subjects performed even better than the BtSt subjects, pressing no more than one or two LEDs adjacent to the target on almost all of the trials (mean trials to hit 2.5, median 2, mode 1; t(70) = 4.6, p<0.0001, prep = 1.0, d = 1.1.
Firstly, descriptions of trial methods was vague for almost all included trials and so the risk of bias was unclear, Secondly, the main evidence was from just three trials (from Afghanistan, Venezuela and Iran), which makes broad generalization to different epidemiological settings and cultures difficult.
The meta-analysis in our review showed an effect of methylphenidate on some outcomes but because we identified that almost all of the trials have a high risk of bias, we do not know the true intervention effect.
What should be noted is that almost all publications of trials of prophylactic antibiotics or probiotics lack a discussion on standard preventive measures against VAP.
LVEF, left ventricular ejection fraction This field clearly benefited from the advancements in imaging sciences as almost all clinical trials involved the use of one or more imaging techniques to evaluate the therapeutic efficacy of stem cell transplantion.
Interestingly, as seen in almost all clinical trials with EPO, the incidence of both adverse and serious adverse events was significantly higher in the EPO arm (94/125 patients) than the placebo arm (50/97 patients), with five deaths due to myocardial infarction, stroke, or stent thrombosis occurring in the EPO group only.
> -wrap-foot> allost all recent clinical trials of novel LN therapeutics have followed a similar generic design: addition of a novel agent or placebo to standard-of-care therapy in any patient having active LN with an expectation that there will be a higher rate of CRR and/or PRR 6 12 months later in the active drug arm.
